Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

The future of molecular diagnostics for drug-resistant tuberculosis.

Heysell SK, Houpt ER.

Expert Rev Mol Diagn. 2012 May;12(4):395-405. doi: 10.1586/erm.12.25. Review.

PMID:
22616704
2.

The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region.

Gikalo MB, Nosova EY, Krylova LY, Moroz AM.

J Antimicrob Chemother. 2012 Sep;67(9):2107-9. doi: 10.1093/jac/dks178. Epub 2012 May 16.

PMID:
22593564
3.

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.

Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC.

PLoS One. 2012;7(3):e33275. doi: 10.1371/journal.pone.0033275. Epub 2012 Mar 29. Review.

4.

Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

Ignatyeva O, Kontsevaya I, Kovalyov A, Balabanova Y, Nikolayevskyy V, Toit K, Dragan A, Maxim D, Mironova S, Kummik T, Muntean I, Koshkarova E, Drobniewski F.

J Clin Microbiol. 2012 May;50(5):1593-7. doi: 10.1128/JCM.00039-12. Epub 2012 Feb 29.

5.

Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

BMC Infect Dis. 2012 Feb 10;12:37. doi: 10.1186/1471-2334-12-37.

6.

GenoType MTBDRsl performance on clinical samples with diverse genetic background.

Miotto P, Cabibbe AM, Mantegani P, Borroni E, Fattorini L, Tortoli E, Migliori GB, Cirillo DM.

Eur Respir J. 2012 Sep;40(3):690-8. doi: 10.1183/09031936.00164111. Epub 2012 Jan 20.

7.

Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.

Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

Int J Tuberc Lung Dis. 2012 Jan;16(1):104-9. doi: 10.5588/ijtld.10.0600.

PMID:
22236854
8.

Current developments and future perspectives for TB diagnostics.

Palomino JC.

Future Microbiol. 2012 Jan;7(1):59-71. doi: 10.2217/fmb.11.133. Review.

PMID:
22191447
9.

GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.

Lacoma A, García-Sierra N, Prat C, Maldonado J, Ruiz-Manzano J, Haba L, Gavin P, Samper S, Ausina V, Domínguez J.

J Clin Microbiol. 2012 Jan;50(1):30-6. doi: 10.1128/JCM.05274-11. Epub 2011 Nov 9.

10.

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM; QUADAS-2 Group..

Ann Intern Med. 2011 Oct 18;155(8):529-36. doi: 10.7326/0003-4819-155-8-201110180-00009.

PMID:
22007046
11.

Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.

Kontsevaya I, Mironova S, Nikolayevskyy V, Balabanova Y, Mitchell S, Drobniewski F.

J Clin Microbiol. 2011 Aug;49(8):2832-7. doi: 10.1128/JCM.01889-10. Epub 2011 Jun 1.

13.

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.

Almeida Da Silva PE, Palomino JC.

J Antimicrob Chemother. 2011 Jul;66(7):1417-30. doi: 10.1093/jac/dkr173. Epub 2011 May 9. Review.

PMID:
21558086
14.

Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.

Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL.

Int J Tuberc Lung Dis. 2011 Jan;15(1):116-24.

PMID:
21276307
15.

Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis.

Kiet VS, Lan NT, An DD, Dung NH, Hoa DV, van Vinh Chau N, Chinh NT, Farrar J, Caws M.

J Clin Microbiol. 2010 Aug;48(8):2934-9. doi: 10.1128/JCM.00201-10. Epub 2010 Jun 23.

16.

Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.

van Ingen J, Simons S, de Zwaan R, van der Laan T, Kamst-van Agterveld M, Boeree MJ, van Soolingen D.

J Clin Microbiol. 2010 Aug;48(8):2749-53. doi: 10.1128/JCM.00652-10. Epub 2010 Jun 16.

17.

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J.

Lancet. 2010 May 22;375(9728):1830-43. doi: 10.1016/S0140-6736(10)60410-2.

PMID:
20488523
18.

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W.

J Clin Microbiol. 2010 May;48(5):1683-9. doi: 10.1128/JCM.01947-09. Epub 2010 Mar 24.

19.

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.

Zaunbrecher MA, Sikes RD Jr, Metchock B, Shinnick TM, Posey JE.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20004-9. doi: 10.1073/pnas.0907925106. Epub 2009 Nov 11.

20.

Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results.

Plinke C, Cox HS, Kalon S, Doshetov D, Rüsch-Gerdes S, Niemann S.

Tuberculosis (Edinb). 2009 Nov;89(6):448-52. doi: 10.1016/j.tube.2009.09.001. Epub 2009 Oct 2.

PMID:
19800845

Supplemental Content

Support Center